Afsaneh Barzi

Oncology
1500 Duarte Rd
Duarte, CA 91010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Correction: Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.

Correction: Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2026

Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis.

Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis.

Journal: Gastro hep advances
Published: July 22, 2025

Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer.

Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer.

Journal: Journal of medical economics
Published: April 23, 2025

Patient-Physician Communication Experience Modifies Racial/Ethnic Health Care Disparities Among Surveillance, Epidemiology, and End Results-Consumer Assessment of Healthcare Providers and Systems Participants With Colorectal Cancer and Multiple Chronic Conditions.

Patient-Physician Communication Experience Modifies Racial/Ethnic Health Care Disparities Among Surveillance, Epidemiology, and End Results-Consumer Assessment of Healthcare Providers and Systems Participants With Colorectal Cancer and Multiple Chronic Conditions.

Journal: Medical care
Published: December 31, 2024

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 30, 2024

USPSTF Recommendations and Colorectal Cancer in Younger Adults-Current Challenges and Future Opportunities.

USPSTF Recommendations and Colorectal Cancer in Younger Adults-Current Challenges and Future Opportunities.

Journal: JAMA network open
Published: October 03, 2024

Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases.

Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases.

Journal: Future oncology (London, England)
Published: September 12, 2024

Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.

Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.

Journal: JAMA health forum
Published: May 31, 2024

Improving survival in metastatic colorectal cancer through optimized patient selection.

Improving survival in metastatic colorectal cancer through optimized patient selection.

Journal: Clinical advances in hematology & oncology : H&O
Published: May 28, 2024

Review of third-line treatment strategies in refractory metastatic colorectal cancer.

Review of third-line treatment strategies in refractory metastatic colorectal cancer.

Journal: Clinical advances in hematology & oncology : H&O
Published: May 28, 2024

How best to extend overall survival in metastatic colorectal cancer: Q&A.

How best to extend overall survival in metastatic colorectal cancer: Q&A.

Journal: Clinical advances in hematology & oncology : H&O
Published: May 28, 2024

Sequencing considerations in the third-line treatment of metastatic colorectal cancer.

Sequencing considerations in the third-line treatment of metastatic colorectal cancer.

Journal: The American journal of managed care
Published: May 03, 2024
Showing 1-12 of 100

Last Updated: 09/26/2026